ABSTRACT. Interleukin 4 (IL-4) is an important regulatory cytokine produced by activated T lymphocytes and mast cells, and regulates the growth and differentiation of cells such as B and T lymphocytes. In the present study, recombinant thioredoxin (Trx)-porcine IL-4 (pIL-4) fusion protein was prepared by Escherichia coli (E. coli), and by using this protein as an immunogen, monoclonal antibodies (mAbs) against pIL-4 were produced to establish a basis for a research on immune responses in pigs. Six stable hybridoma cell lines were successfully established and specific binding of each mAb to recombinant pIL-4 produced by E. coli and insect cells infected with recombinant baculovirus was shown by enzyme-linked immunosorbent assay (ELISA) and/or immunoblot analysis. Isotype analyses of these mAbs revealed that the subclass of 5 out of 6 mAbs was IgG1 and the rest was IgG2b. Further, assessment of their epitopes by competition binding assay indicated that the mAbs obtained in this study bound to 4 different epitopes. The recombinant proteins and mAbs produced in this study will be useful tools for the assessment of porcine immune system.
Cytokines are powerful mediators secreted from wide variety cells and regulate a wide spectrum of biological functions. The production of different cytokines by T cells during an immune reaction is shown to have important regulatory effects on the nature of the responses. Initially, it was reported that helper T (Th) cells could be classified into two different subsets according to their cytokine profiles in mice [12] . Later studies showed that these 2 subsets of Th cells could be applied to those in other species on the basis of the pattern of cytokine production [2, 3, 6, 14] . T helper 1 (Th1) cells are characterized by the production of interferon (IFN)-γ, IL-2 and tumor necrosis factor (TNF)-β that induce cellular immune responses, while Th2 cells produce IL-4, IL-5, IL-6, IL-10 and IL-13 that enhance humoral immunity.
Infectious diseases including zoonoses are serious problems in pig industry and human public health. Further, the pig is a useful model for human diseases such as infectious diseases and immune-mediated diseases [8, 18] . In addition, xenograft is intensively studied and the pig is a hopeful candidate for an alternative source of tissues for humans [4] . Thus, assessment of porcine immune system including Th1/ Th2 profile is beneficial to both pigs and humans. At present, most studies on cytokine are done on mRNA level by reverse transcriptase polymerase chain reaction (RT-PCR) method in pigs since no suitable in vitro assay systems are available [15] . However, mRNA levels don't always reflect the amount of active protein production because of its post-transcriptional regulation. Thus, the methods to measure cytokine production on protein level are required. Although bioassay system is a helpful method to measure bioactivity of cytokines, this system is time-consuming, labor-intensive, unreliable, and affected by many variables including culture reagents, suppressive factors and other growth factors [9] . Enzyme-linked immunosorbent assay (ELISA) is a powerful method to measure cytokines on protein level. This method is simple, rapid and highly reliable and widely used for assessment of cytokine responses. Although mAbs are indispensable for establishment of this system, few mAbs to porcine cytokines are available.
In the present study, recombinant pIL-4 was expressed by E. coli and purified as a fusion protein. By using this fusion protein as an immunogen, six mAbs specific for pIL-4 that bound to 4 different epitopes were produced.
MATERIALS AND METHODS

Production of recombinant pIL-4 by E. coli and baculovirus:
In order to obtain recombinant pIL-4 produced by E. coli, XhoI adaptor-ligated pIL-4 cDNA fragment without a signal sequence was inserted into the XhoI site of the Trx fusion plasmid vector, pET-32b(+) (Novagen, Darmstadt, Germany). E. coli, BL21 cells (Novagen) were transformed with the recombinant plasmid and grown in LB medium containing ampicillin (50 µg/ml). Production of Trx-pIL-4 fusion protein was induced by addition of isopropyl β-Dthiogalactoside (IPTG) to a final concentration of 1 mM. These BL21 cells suspended in ice-cold binding buffer (5 mM imidazole, 0.5 M NaCl and 20 mM Tris-HCl, pH 7.9) were sonicated and treated with 1% Triton X-100 followed by centrifugation at 12,000 g for 10 min at 4°C. The TrxpIL-4 fusion protein was obtained by purification of the supernatant with His-Bind Resin (Novagen). The Trx protein was obtained using the same procedure as a control.
For production of recombinant pIL-4 by baculovirus, without adjuvant. Three days after the final injection, the blood was collected from the mice and centrifuged at 8,500 g for 10 min at 4°C. These serum samples were subjected to detection of antigen-specific antibody responses by ELISA. Hybridoma production: Single-cell suspensions of spleen from immunized mice were prepared as described previously [20] . Briefly, fresh splenocytes were suspended in NS-1 medium (RPMI1640 containing 10% FCS, 2 mM glutamine, 1 mM sodium pyruvate, 50 IU/ml penicillin and 50 µg/ml streptomycin) and centrifuged at 400 g for 5 min at room temperature (RT). The cells were treated with 0.83% NH 4 Cl-Tris (pH 7.6) followed by washing twice with NS-1 medium and resuspended in NS-1 medium.
Cell fusion was performed by the previously established method [5, 7] . In brief, splenocyte and P3U1 mouse myeloma cells were mixed at 5:1 ratio and centrifuged at 400 g for 5 min at RT. After washing with serum-free NS-1 medium, 1 ml of 50% polyethylene glycol 4,000 (MERCK, Damstadt, Germany) was added with vigorous agitation. Then, 10 ml of serum-free NS-1 medium was added and the cells were recovered by centrifugation at 170 g for 5 min at RT. The cells were resuspended into HAT selection medium (NS-1 medium containing 100 µM hypoxantine, 0.4 µM aminopterin and 16 µM thymidine) and seeded in 96-well flat bottom microplate (IWAKI, Tokyo, Japan) (5 × 10 5 per well). The cells were cultured at 37°C in a humidified 5% CO 2 atmosphere. Supernatants from wells showing hybridoma cell growth were screened for antibodies to pIL-4 using ELISA described below.
Enzyme-linked immunosorbent assay (ELISA): 96-well flat bottom microplate (NUNC A/S, Roskilde, Denmark) was coated with 500 ng/ml of Trx or Trx-pIL-4 fusion protein in 50 mM carbonate buffer (15 mM Na 2 CO 3 and 35 mM NaHCO 3 , pH 9.6) for 2 hr at RT. After blocking with 2% gelatin in PBS for 1 hr at RT, hybridoma cell culture supernatants or purified mAbs were added to each well. After incubation for 1 hr at RT, peroxidase-conjugated goat IgG fraction against mouse IgG Fc (CAPPEL, West Chester, PA) were used. The color reaction was developed with 0.04 % orthophenylene diamine in 0.05 M citric acid/0.1 M Na 2 HPO 4 buffer containing 0.02% H 2 O 2 . The reaction was stopped by addition of 2.5 M H 2 SO 4 and absorbance was read by microplate reader (BIO-RAD, Hercules, CA) at a test wavelength of 490 nm and a reference wavelength of 630 nm.
Competition binding assay: MAbs were purified from supernatant of the hybridoma cell culture by using MAbTrap Kit (AmershamPharmacia BiotechAB, Uppsala, Sweden) according to the manufacturer's instruction.
To determine the amount of each mAb required for saturation of Trx-pIL-4 fusion protein, various concentrations of mAbs specific for pIL-4 were added to each well coated with 500 ng/ml of Trx-pIL-4 and assessed the reactivity by ELISA as described above. The lowest concentration of mAbs required to reach the maximum reaction level was qualified as the saturated concentration. For assessment of epitope variations among mAbs, purified mAbs were biotinylated by ECL Protein Biotinilation Module (Amersham Pharmacia BiotechAB) and used for competition binding assay. Microplates were coated with 500 ng/ml of Trx-pIL-4 fusion protein and saturated or diluted amount of unlabeled mAbs specific for pIL-4 was added to each well after blocking with 2% gelatin in PBS. After incubation for 1 hr at RT, competition among mAbs was assessed by binding of biotinylated mAbs to coated Trx-pIL-4 fusion protein in the presence of saturated unlabeled mAbs. For detection, horseradish peroxidase (HRP) labeled streptavidin was used. The color reaction was developed as described above.
Isotype analysis of mAbs: Isotype analyses of mAbs were performed by using Mouse Monoclonal Antibody Isotyping Kit (Amersham Pharmacia BiotechUK, Buckinghamshire, England) according to the manufacturer's instruction.
Immunoblot analysis: Cell lysates of E. coli transformed with pIL-4 cDNA-inserted expression plasmid or recombinant baculovirus-infected Sf9 cells were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reduced condition in the presence of 1,4-dithiothreitol (DTT) and transferred electrophoretically to polyvinylidene difluoride membranes (MILLIPORE, Bedford, MA). After blocking with 5% skim milk in PBS containing 0.1% Tween 20 (PBS-T) for 1 hr at RT, the membranes were incubated with purified mAbs against pIL-4 for 1 hr at RT and washed three times with PBS-T. The membranes were further incubated with alkaline phosphatase-conjugated rabbit anti-mouse IgG antibody (SIGMA, St Louis, MO) for 40 min at RT. After three washes with PBS-T, the blots were developed by addition of substrate (Alkaline Phosphatase Conjugate Substrate Kit; BIO-RAD) and visualized.
RESULTS
Production and purification of recombinant Trx-pIL-4 fusion protein:
To establish recombinant pIL-4 expression system, we inserted pIL-4 cDNA fragment without a signal sequence into the eukaryotic expression plasmid vector, pET-32b (+). A pET-32b (+) plasmid containing cDNA encoding the 109 amino acid residues of the pIL-4 was introduced into E. coli, BL21 cells, and Trx-pIL-4 fusion protein was purified after incubation with IPTG. Purified Trx-pIL-4 fusion protein had a molecular mass of about 32 kDa based on polyacrylamide gel electrophoresis (Fig. 1) .
Production and characterization of mAbs to pIL-4: Using a purified Trx-pIL-4 fusion protein as an immunogen, we attempted to obtain mAbs specific for pIL-4. Screening of hybridoma cells producing anti-pIL-4 antibody was performed by ELISA. Supernatants from seventy-nine hybridoma clones were proved to react with Trx-pIL-4 fusion protein. Among these, fifteen clones were shown to produce antibodies that bound to Trx-pIL-4 fusion protein but not to Trx only. These hybridoma cells were further cloned by limiting dilution and six independent clones referred to as 1E-7, 2A-6, 2G-3, 2G-4, 3F-4 and 3F-7 were finally established.
Isotype analyses of mAbs produced by these clones revealed that five out of six were IgG1 and the other one was IgG2b, and all mAbs had κ-light chains (data not shown).
All mAbs were tested their reactivity to pIL-4 by ELISA and immunoblot analysis using E. coli-derived recombinant protein as an antigen. All the six mAbs reacted with TrxpIL-4 fusion protein but not with Trx protein only, indicating that these mAbs specifically bound to pIL-4. The representative data using 2G-3 mAb was shown in Fig. 2 . The mAbs were also tested by immunoblot analysis for their reactivity with recombinant pIL-4 expressed in insect cells by baculovirus. As represented by the data using 3F-4 mAb in Fig. 3 , all mAbs bound to single protein with an approximate molecular mass of 14 kDa that was considered to be recombinant pIL-4 protein expressed by baculovirus. These results indicated that six mAbs obtained specifically recognized pIL-4 protein.
Relative affinity of mAbs against recombinant pIL-4:
Purified mAbs were assessed their titers against pIL-4 by ELISA (Table 1) . Titers were defined as the concentration of antibody required to obtain an optical density of 1.0 after 10 min of revelation. 2G-3 and 3F-4 mAbs presented the lower titer for the recombinant pIL-4 (4.7 and 2.9 µg/ml, respectively) while the other mAbs presented a higher reactivity against pIL-4 (between 0.3 and 0.6 µg/ml).
Epitope analysis of mAbs by competition binding assay:
To examine whether the six mAbs obtained in this study could recognize different epitopes on pIL-4 or not, competition binding assay was performed. In the preliminary study, the amount of each mAb that saturates coated antigen was addressed (data not shown). 2A-6 mAb was labeled with biotin and assessed its binding ability to Trx-pIL-4-coated plate pre-incubated with saturated or diluted amount of unlabeled purified mAbs. As shown in Fig. 4A , biotinlabeled 2A-6 mAb was inhibited its binding to pIL-4 by the increasing amounts of 2G-4 or 3F-7 mAb strongly and 1E-7 mAb intermediately but not by 2G-3 or 3F-4 mAb. Similar result was obtained by using a labeled 2G-4 mAb, which was blocked its binding to coated antigen by 2A-6 or 3F-7 mAb strictly and 1E-7 mAb partly but not by 2G-3 or 3F-4 mAb (Fig. 4B) . These results showed that the epitope recognized by 2A-6 mAb was identical with 2G-4 and 3F-7 mAbs and partly overlapped with 1E-7 mAb but different from 2G-3 or 3F-4 mAb. Further, when biotinylated 3F-4 mAb was used, no inhibition was observed by any other saturated amount of mAbs (Fig. 4C) , indicating that 3F-4 mAb bound to a unique epitope, which was different from that of 2G-3 mAb. These data showed that six mAbs obtained in this study recognized four different epitopes.
DISCUSSION
In the present study, recombinant Trx-pIL-4 fusion protein was expressed by E. coli, purified and used as an immunogen for production of mAbs against pIL-4. Six stable hybridoma cell lines were established, and specific binding of each mAb to recombinant pIL-4 produced by eukaryotic cells as well as E. coli was shown by ELISA and/or immunoblot analysis. In addition, the mAbs were shown to recognize four different epitopes by competition binding assay.
IL-4 is a product of activated T lymphocytes originally identified as a costimulator of B lymphocyte proliferation [10] . This cytokine is now considered to be a representative one produced by Th2 cells and typical indicator of Th2-type reactions while IFN-γ is believed to be a representative Th1-type cytokine [1, 16, 17] . Therefore, the differential expression of these two cytokines, IL-4 and IFN-γ was intensively studied for monitor the immunological status in the host, and these investigations have given us interesting and useful information for veterinary immunology as well as human science.
The pig is recognized as a useful model for human diseases such as infectious diseases and immune-mediated disorders. Further, it is a hopeful candidate for an alternative source of tissues for humans. Thus, assessment of porcine immune system including Th1/Th2 profile is beneficial to human as well as pig. Up to date, cytokine responses ware largely assessed on mRNA level in pigs since few assay systems are established on protein level. However, mRNA levels don't always correlate with the amount of protein. In order to establish a basis for research on immune response and immune-mediated diseases in the pig, we attempted to produce mAbs that could specifically bind to representative Th2-type cytokine, IL-4.
In the present study, we expressed recombinant pIL-4 in E. coli to obtain a sufficient amount of immunogen since it is impossible to purify enough doses of natural pIL-4 for immunization. Two popular methods, GST and Trx fusion protein expression systems were applied for this purpose, and Trx fusion protein expression system was more efficient than that of GST for protein production and purification (data not shown). Therefore, recombinant Trx-pIL-4 fusion protein was used for immunization and following experiments. Using the recombinant protein as an immunogen, we successfully established six mAbs that specifically bind to pIL-4. The reaction of mAbs with pIL-4 was initially assessed by use of recombinant Trx-pIL-4 protein produced by E. coli as an antigen. However, eukaryotic proteins expressed in E. coli are not properly modified, and mAbs produced by immunization with E. coli-derived recombinant protein may not react with the same protein produced by mammalian cells. Thus, we addressed this issue and showed that all mAbs obtained in this study reacted with modified pIL-4 protein produced by insect cells infected with recombinant baculovirus, strongly suggesting that these mAbs would recognize natural form of pIL-4.
In conclusion, we successfully produced mAbs that reacted with four different epitopes in natural form of pIL-4. At present, several mAbs against pIL-4 was commercially available; however, the generation of new mAbs to pIL-4 should allow the development of an antigen capture ELISA which would enable the sensitive and quantitative measurement of pIL-4 generated upon stimulation of the immune system in response to a variety of infection and immunemediated diseases [11, 13] . In addition, establishment of detection system of intracellular cytokines by use of flow cytometric analysis will make it possible to monitor the ratio of Th1 or Th2-type cytokine producing cells in peripheral blood [19] . Finally, since the pig is known as a helpful animal for assessment of human diseases, the findings expected to be accumulated through these studies will also provide useful information on human science as an animal model. (B) and 3F-4 (C), were labeled with biotin and assessed their binding ability to Trx-pIL-4-coated microplates pre-incubated with saturated or diluted amount of unlabelled competitor mAbs.
